Lorenzoni PJ, Scola RH, Kay CS, et al. When should MERR F (myoclonus epilepsy associated with ragged-red fibers) be the diagnosis? Arq Neuropsiquiatr 2014; 72: 803–811.
Rossmanith W, Raffelsberger T, Roka J, et al. The expanding mutational spectrum of MERR F substitution G8361A in the mitochondrial tRNAL ys gene. Ann Neurol 2003; 54: 820–823.
Van Goethem G, Mercelis R, Löfgren A, et al. Patient homozygous for a recessive POL G mutation presents with features of MERRF. Neurology 2003; 61: 1811–1813.
Blakely EL , Trip SA , Swalwell H, et al. A new mitochondrial transfer RNAPro gene mutation associated with myoclonic epilepsy with ragged-red fibers and other neurological features. Arch Neurol 2009; 66: 399–402.
Hayashi G, Cortopassi G. Oxidative stress in inherited mitochondrial diseases. Free Radic Biol Med 2015; 88: 10–17.
James AM, Sheard PW, Wei YH, et al. Decreased AT P synthesis is phenotypically expressed during increased energy demand in fibroblasts containing mitochondrial tRNA mutations. Eur J Biochem 1999; 259: 462–469.
Fukuhara N, Tokiguchi S, Shirakawa K, et al. Myoclonus epilepsy associated with ragged-red fibres (mitochondrial abnormalities):disease entity or a syndrome? Light-and electron-microscopic studies of two cases and review of literature. J Neurol Sci 1980; 47: 117–133.
Catteruccia M, Sauchelli D, Della Marca G, et al. „Myo-cardiomyopathy” is commonly associated with the A8344G „MERR F”mutation. J Neurol 2015; 262: 701–710.
Blakely EL , Alston CL, Lecky B, et al. Distal weakness with respiratory insufficiency caused by the m.8344A > G „MERR F”mutation. Neuromuscul Disord 2014; 24: 533–536.
DiMauro S, Hirano M, Kaufmann P, et al. Clinical features and genetics of myoclonic epilepsy with ragged red fibers. Adv Neurol 2002; 89: 217–229.
Mancuso M, Orsucci D, Angelini C, et al. Phenotypic heterogeneity of the 8344A>G mtDNA „MERR F” mutation. Neurology 2013; 80: 2049–2054.
Bourgeois JM, Tarnopolsky MA. Pathology of skeletal muscle in mitochondrial disorders. Mitochondrion 2004; 4: 441–452.
Hasegawa H, Matsuoka T, Goto Y, et al. Cytochrome c oxidase activity is deficient in blood vessels of patients with myoclonus epilepsy with ragged-red fibers. Acta Neuropathol 1993; 85: 280–284.
Ito S, Shirai W, Asahina M, et al. Clinical and brain MR imaging features focusing on the brain stem and cerebellum in patients with myoclonic epilepsy with ragged-red fibers due to mitochondrial A8344G mutation. AJNR Am J Neuroradiol 2008; 29(2): 392–395.
Teive HA, Munhoz RP, Muzzio JA, et al. Cerebellar ataxia, myoclonus, cervical lipomas, and MERR F syndrome. Case report.Mov Disord 2008; 23(8): 1191–1192.
. Anglin RE , Rosebush PI, Noseworthy MD, et al. Metabolite measurements in the caudate nucleus, anterior cingulate cortex and hippocampus among patients with mitochondrial disorders: a case-control study using proton magnetic resonance spectroscopy.CMAJ Open 2013; 1(1): E48–E55.
Lorenzoni PJ, Scola RH, Kay CS, et al. MERR F: clinical features, muscle biopsy and molecular genetics in Brazilian patients.Mitochondrion 2011; 11: 528–532.
Zsurka G, Becker F, Heinen M, et al. Mutation in the mitochondrial tRNA(Ile) gene causes progressive myoclonus epilepsy.Seizure 2013; 22: 483–486.
Ozawa M, Goto Y, Sakuta R, et al. The 8,344 mutation in mitochondrial DNA: a comparison between the proportion of mutantDNA and clinico-pathologic findings. Neuromuscul Disord 1995; 5: 483–488.
Sinha S, Satishchandra P, Gayathri N, et al. Progressive myoclonic epilepsy: a clinical, electrophysiological and pathological study from South India. J Neurol Sci 2007; 252(1): 16–23.
Romani A, Galimberti CA, Callieco R, et al. Median nerve SSE PS and C reflexes to double stimuli in a MERR F patient. Clin Neurophysiol 1996; 98(5): P74.
Tanaka S, Osari S, Ozawa M, et al. Recurrent pain attacks in a 3-year-old patient with myoclonus epilepsy associated with ragged-red fibers (MERR F): a single-photon emission computed tomographic (SPECT) and electrophysiological study. Brain Dev 1997; 19(3): 205–208.
Chandra SR , Issac TG, Gayathri N, et al. A typical case of myoclonic epilepsy with ragged red fibers (MERR F) and the lessons learned. J Postgrad Med 2015; 61: 200–202
Shahwan A, Farrell M, Delanty N. Progressive myoclonic epilepsies: a review of genetic and therapeutic aspects. Lancet Neurol 2005; 4: 239–448.
Finsterer J, Zarrouk Mahjoub S. Mitochondrial toxicity of antiepileptic drugs and their tolerability in mitochondrial disorders.Expert Opin Drug Metab Toxicol 2012; 8(1): 71–79.
Tarnopolsky MA. The mitochondrial cocktail: rationale for combined nutraceutical therapy in mitochondrial cytopathies. Adv Drug Deliv Rev 2008; 60: 1561–1567.